|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
Click here for printer friendly page
Granville Baird to acquire majority stake in Amoena Group13/02/2007. Source: AltAssets. 
 Granville Baird Capital Partners Advisers has agreed to acquire Raubling, Germany-headquartered Amoena Group in a management buy-out transaction from the Danish medical devices company Coloplast for a purchase price of €102.25m. The current management team of Amoena will acquire a stake in the company alongside the funds advised by Granville Baird.
Amoena employs 600 people and manufactures and distributes breast prostheses for women who have undergone surgery following the detection of breast cancer. To complement its product portfolio, the company also sells related products such as bras and swimwear designed to hold the breast forms. Amoena has been a subsidiary of Coloplast since the mid 1990s.
‘Amoena is the global market leader with operations in over 60 countries,’ said Mathias Schirmer, partner, Granville Baird. ‘The company’s commitment to innovation and its broad, international distribution network are a strong basis for further profitable growth.’
Granville Baird specialises in management buy-outs and the funding of growing medium-sized companies in Germany. Granville Baird is the exclusive advisor to Baird Capital Partners Europe.
Copyright © 2007 AltAssets
|
 
|
|
|
